Podcast brought to you by: BioConference Live's annual Clinical Diagnostics Conference, May 29-31
Steve Burrill, CEO, Burrill and Co Bio and Contact Info
Listen (4:38) Burrill and Buck Conference on Aging
Listen (7:32) Moving to a world in healthcare where we will pay for outcomes
Listen (6:23) Has it not always been about values?
Listen (4:24) Can Pharma create value outside of providing drugs?
Listen (1:08) Thoughts on gene patent case
"This is not your grandfather’s Buick anymore. If you grew up in biotech any time prior to the last five years, you need to reexamine your assumptions about the world of reimbursement." Ron Cohen, CEO, Acorda
This quote is taken from the yearly state of the industry book put out by Burrill and Company. CEO, Steve Burrill joins us today to discuss the newly published book this year subtitled, "Capturing Value." Cohen's quote summarizes the message in the book in which Burrill and his team argue persuasively that things in healthcare are not the way they used to be, that we are moving from a "cost-based" to a "value-based" system. Steve discusses this paradigm shift in today's show and explains why we need new assumptions in the world of pharma and biotech.
Early in the interview, Steve previews the first Burrill and Buck Aging Conference coming up May 20-21 in Novato California. The interview ends with Burrill's thoughts on the Myriad gene patent case.